VEGF165 and HGF both have been shown to have a neurotrophic modality via corresponding signaling axes [37,38] and this has become the basis for their application in peripheral nerve injury, central nerve system diseases and neuropathic conditions [39,40]. The gene discussed is HGF; the disease is peripheral nerve injury.